Stay updated on Brentuximab Vedotin Plus Pembrolizumab Clinical Trial
Sign up to get notified when there's something new on the Brentuximab Vedotin Plus Pembrolizumab Clinical Trial page.

Latest updates to the Brentuximab Vedotin Plus Pembrolizumab Clinical Trial page
- Check5 days agoChange DetectedThe list of study locations was updated to 90 sites, with a new Dallas, Texas (75246) site at Texas Oncology added and several other centers removed.SummaryDifference0.5%

- Check12 days agoChange DetectedThe page's revision label was updated from v3.6.2 to v3.6.3, marking a new iteration of the study record.SummaryDifference0.0%

- Check19 days agoChange DetectedThe page’s revision label has been updated from Revision: v3.6.0 to Revision: v3.6.2, indicating a new build of the page. This appears to be a minor maintenance update rather than a substantive change to study content.SummaryDifference0.0%

- Check33 days agoChange DetectedThe page now indicates recruitment is closed for the study; additional help/navigation links were added and the Intervention/Treatment heading formatting was adjusted.SummaryDifference0.2%

- Check41 days agoChange DetectedRevision tag updated from v3.5.4 to v3.5.5, signaling a new version of the page. This appears to be a meta update indicating a page refresh or minor changes rather than core content changes.SummaryDifference0.0%

- Check62 days agoChange DetectedThe page revision was updated from v3.5.3 to v3.5.4, indicating a newer version of the study record. This appears to be a metadata update rather than a substantive change to the study details.SummaryDifference0.0%

Stay in the know with updates to Brentuximab Vedotin Plus Pembrolizumab Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Brentuximab Vedotin Plus Pembrolizumab Clinical Trial page.